Research and Markets: Optina (Microvascular Complications of Diabetes) - Forecast and Market Analysis to 2022 Report
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/zb72hn/optina) has announced the addition of the "Optina (Microvascular Complications of Diabetes) - Forecast and Market Analysis to 2022" report to their offering.
“Optina (Microvascular Complications of Diabetes) - Forecast and Market Analysis to 2022”
The entire market for microvascular complications of diabetes (MCD) - diabetic nephropathy, retinopathy, and neuropathy - is facing an extremely high level of unmet need across the 7MM (US, 5EU and Japan). Despite its enormous potential, the MCD market is facing the major global barrier in the sparsely populated pipeline.
The diabetic retinopathy segment of the market has recently seen rapid uptake of novel anti-VEGF therapies and is experiencing a strong growth. On the other hand, the diabetic neuropathy and nephropathy segments face the barrier in and increasing number of generic competitors.
Optina (danazol) has been developed by Ampio Pharmaceuticals and is currently in Phase III trials for the treatment of diabetic retinopathy and DME. Effective non-surgical drug treatment of diabetic retinopathy is a high unmet need and Optina is the only drug in late-phase development addressing this need.
- Overview of MCD, including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.
- Detailed information on Optina including product description, safety and efficacy profiles as well as a SWOT analysis.
- Sales forecast for Optina for the top seven countries from 2012 to 2022.
- Sales information covered for the US, France, Germany, Italy, Spain, the UK and Japan.
Key Topics Covered:
List of Tables
List of Figures
Opportunity and Unmet Need
For more information visit http://www.researchandmarkets.com/research/zb72hn/optina
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.